原创出品:《巴论财经》作者:新巴论巴论财经观察,山东威高血液净化制品股份有限公司(简称:威高血净)于2月26日接受上市委的审议,此次IPO,威高血净拟募资13.51亿元,资金将主要用于智能化生产建设、透析器(赣州)生产基地建设、研发中心建设及数字化信息技术平台建设项目等。然而,市场对公司IPO质疑声不断引发市场的关注。威高血净成立于2004年,专注于血液净化领域,控股股东为威高集团。据悉,威高集团...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.